Technology infrastructures for drug development In our GMP laboratories, we produce materials for clinical studies. We perform preclinical safety studies and toxicological analyses through GLP accreditation. Test & demo 3D-Bioprinting Through 3D-printing it is possible to build biological structures by combining a biological, or synthetic material, with living cells. 3D-printing can e.g. be used to evaluate biological responses to pharmaceuticals or chemicals and can also be used in the development of future human spare parts. Within the manufacturing process, RISE develops competence and studies the characteristics and functions of 3D-Bioprinting systems.